Scholarly Index
Emiel J. Rutgers
The Netherlands Cancer Institute; 54,498 total citations; 672 total publications; best world rank #12
The Netherlands Cancer Institute
54,498Total citations
672Total publications
97H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Lesions and Carcinomas | Lifetime | 12 | NL 1 | 99.80 |
| Breast Cancer Treatment Studies | Lifetime | 33 | NL 1 | 99.85 |
| Breast Implant and Reconstruction | Lifetime | 13 | NL 1 | 99.65 |
| Cancer Diagnosis and Treatment | Lifetime | 101 | NL 4 | 99.17 |
| Cancer Genomics and Diagnostics | Lifetime | 399 | NL 11 | 99.24 |
| BRCA gene mutations in cancer | Lifetime | 145 | NL 6 | 98.75 |
| Global Cancer Incidence and Screening | Lifetime | 322 | NL 11 | 98.33 |
| HER2/EGFR in Cancer Research | Lifetime | 448 | NL 11 | 98.09 |
| Advanced Breast Cancer Therapies | Lifetime | 281 | NL 3 | 97.73 |
| Clinical practice guidelines implementation | Lifetime | 707 | NL 59 | 93.70 |
| Multiple and Secondary Primary Cancers | Lifetime | 852 | NL 31 | 92.39 |
| Lymphatic Disorders and Treatments | Lifetime | 654 | NL 8 | 62.20 |
| Breast Cancer Treatment Studies | 2021-2025 | 322 | NL 15 | 96.39 |
| Breast Lesions and Carcinomas | 2021-2025 | 356 | NL 19 | 86.04 |
| Advanced Breast Cancer Therapies | 2021-2025 | 742 | NL 10 | 86.55 |
| Breast Implant and Reconstruction | 2021-2025 | 633 | NL 26 | 80.16 |